Komori
M&A and Subsidiary Changes3359cotta CO.,LTDTrading & Wholesale

Notice Regarding the Acquisition of Shares by a Consolidated Subsidiary (Making the Company a Sub-subsidiary)

Works, Inc., a consolidated subsidiary, has decided to acquire 51% of the shares of MedMarge Co., Ltd., making MedMarge a sub-subsidiary of the Company and a consolidated subsidiary. The Group will establish a framework for providing aesthetic medical services, including hair-loss treatment, by leveraging its hair salon network.

Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
19
¥100 million (expected first-year transaction volume)
Wording
Conditional
How definitive the wording is.

This transaction

Share acquisition (making the target a grand-subsidiary)
CounterpartyNot disclosed in accordance with the counterparty's wishes (2 individuals)
Disclosing companycotta CO.,LTD
MedMarge Co., Ltd.Voting rights ownership percentageNumber of shares acquired 5,100 shares (51%); number of voting rights: Not disclosed

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.

TimelineThe spacing between the points is proportional to the actual number of days.
Target company

Various information services using the Internet Planning, production, sale, operation and management of websites, etc.

Location Shinjuku-ku, TokyoShare capital ¥1,000,000Date of incorporation 3 June 2022
Net Sales¥191 million (forecast for the fiscal year ending April 2026)
Operating profit¥77 million (forecast for the fiscal year ending April 2026)
Net income for the current fiscal year¥52 million (forecast for the fiscal year ending April 2026)
Net assetsNegative ¥1 million (fiscal year ended April 2025)
Consideration and expenses
Acquisition priceNot disclosed in accordance with the counterparty's wishes.
Impact on Business Performance

The impact on consolidated results for the current fiscal year is currently under review.

Procedures and assumptions
Valuation methodologyDetermined based on the results of due diligence by external specialists, taking into account the asset position and other factors
Conditions Precedent to ExecutionThe additional acquisition of equity interests is premised on being carried out in stages based on an agreement between the parties and subject to certain conditions
Management structure after acquisitionThe Company will maintain the continuing involvement of the target company's management and their incentives for business growth, and will operate the business by leveraging the expertise of the existing management team
This transaction
ItemDetails
Transaction nameShare acquisition (making the target a grand-subsidiary)
Counterparty nameNot disclosed in accordance with the counterparty's wishes (2 individuals)
Name of the Subject CompanyMedMarge Co., Ltd.
Business Description of the Subject CompanyVarious information services using the Internet Planning, production, sale, operation and management of websites, etc.
Location of the Subject CompanyShinjuku-ku, Tokyo
Capital Stock of the Subject Company¥1,000,000
Date of Establishment of the Subject Company3 June 2022
Net Sales of the Subject Company¥191 million (forecast for the fiscal year ending April 2026)
Operating Profit of the Subject Company¥77 million (forecast for the fiscal year ending April 2026)
Net Income of the Subject Company¥52 million (forecast for the fiscal year ending April 2026)
Net Assets of the Subject CompanyNegative ¥1 million (fiscal year ended April 2025)
Acquisition priceNot disclosed in accordance with the counterparty's wishes.
Number of shares acquired5,100 shares (51%); number of voting rights: Not disclosed
Voting rights ownership percentageBefore 0% → after 51%
Impact on Business PerformanceThe impact on consolidated results for the current fiscal year is currently under review.
Date of board resolution10 April 2026
Contract Date10 April 2026
Execution Date / Effective DateShare transfer completion date: 11 May 2026 (scheduled). Deemed acquisition date: 30 June 2026 (scheduled)
Valuation methodologyDetermined based on the results of due diligence by external specialists, taking into account the asset position and other factors
Conditions Precedent to ExecutionThe additional acquisition of equity interests is premised on being carried out in stages based on an agreement between the parties and subject to certain conditions
Management structure after acquisitionThe Company will maintain the continuing involvement of the target company's management and their incentives for business growth, and will operate the business by leveraging the expertise of the existing management team
Items this document does not state (11)
Expenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Independent valuation institutionSpecial Committee

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The purpose is to establish a framework for providing customers with aesthetic medical services, including hair-loss treatment, through the hair salon channel, leveraging Works' hair salon network. The Company cites the creation of new revenue opportunities for hair salons, enhancement of value provided to customers, supplementation of its existing businesses, and expansion into the aesthetic medical field as the reasons for the transaction.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Acquisition of Shares by a Consolidated Subsidiary (Making the Company a Sub-subsidiary) | cotta CO.,LTD (3359) timely disclosure | Komori